Soleno Therapeutics Inc (SLNO)

CapEx to Revenue

0.04%

Quarterly · Period ending:

SLNO logo

SLNO CapEx to Revenue

Latest reported0.04%
SLNO Quarterly CapEx/Revenue (0.04% → 0.04%)
High-resolution chart · PNG

SLNO capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Soleno Therapeutics Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
0.0423%
0.0632%
0.0015%
0.0276%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0.349%
0%
300%
1.5094%
0.1128%
0.6079%
5.1151%
4.2506%
44.618%
197.8261%
46.875%
4.5455%
0%
0%
0%
0%
0%
0%
0%
0.0425%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.